PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
-10.14%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$21.7M
AUM Growth
-$3.2M
(-13%)
Cap. Flow
-$376K
Cap. Flow
% of AUM
-1.73%
Top 10 Holdings %
Top 10 Hldgs %
43.52%
Holding
505
New
63
Increased
149
Reduced
122
Closed
49
Top Buys
| 1 |
Ferguson
FERG
|
$276K |
| 2 |
Palo Alto Networks
PANW
|
$92.6K |
| 3 |
Snap
SNAP
|
$91.9K |
| 4 |
Synopsys
SNPS
|
$89.3K |
| 5 |
Unity
U
|
$87.9K |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$160K |
| 2 |
PCGU
PG&E Corporation
PCGU
|
$116K |
| 3 |
Seagate
STX
|
$113K |
| 4 |
Amazon
AMZN
|
$93.2K |
| 5 |
Western Digital
WDC
|
$75.8K |
Sector Composition
| 1 | Technology | 33.51% |
| 2 | Industrials | 22.91% |
| 3 | Healthcare | 16.41% |
| 4 | Financials | 12.26% |
| 5 | Communication Services | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Celldex Therapeutics
CLDX
$1.52B
| $42.6K | 0.19% |
1,250,000
+250,000
| +25% | +$8.52K |
|
102
AngioDynamics
ANGO
$436M
| $40.5K | 0.18% |
1,882,375
+334,649
| +22% | +$7.21K |
|
103
Mercado Libre
MELI
$123B
| $40.5K | 0.18% |
34,055
+117
| +0.3% | +$139 |
|
104
BioMarin Pharmaceuticals
BMRN
$11.1B
| $38.6K | 0.17% |
500,000
+375,000
| +300% | +$28.9K |
|
105
Visa
V
$666B
| $38.1K | 0.17% |
172,008
| – | – |
|
106
First American
FAF
$6.83B
| $38.1K | 0.17% |
587,500
+68,000
| +13% | +$4.41K |
|
|
GBT
107
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $38K | 0.17% |
1,095,810
+175,000
| +19% | +$6.06K |
|
108
T-Mobile US
TMUS
$284B
| $37.7K | 0.17% |
293,371
| – | – |
|
109
Alnylam Pharmaceuticals
ALNY
$59.2B
| $37.5K | 0.17% |
229,833
-305,798
| -57% | -$49.9K |
|
110
Merit Medical Systems
MMSI
$5.51B
| $37.5K | 0.17% |
563,251
-52,370
| -9% | -$3.48K |
|
111
United Rentals
URI
$62.7B
| $37.3K | 0.17% |
105,072
| – | – |
|
112
Alcon
ALC
$39.6B
| $37K | 0.17% |
479,942
-451,552
| -48% | -$34.9K |
|
113
JPMorgan Chase
JPM
$809B
| $35.2K | 0.16% |
258,485
+13,517
| +6% | +$1.84K |
|
|
SBNY
114
DELISTED
Signature Bank
SBNY
| $35.1K | 0.16% |
119,556
-25,258
| -17% | -$7.41K |
|
115
AtriCure
ATRC
$1.76B
| $34.7K | 0.16% |
528,858
+2,100
| +0.4% | +$138 |
|
116
Arcutis Biotherapeutics
ARQT
$2.06B
| $34.4K | 0.16% |
1,784,005
| – | – |
|
117
Y-mAbs Therapeutics
YMAB
$390M
| $34.2K | 0.15% |
2,877,671
+1,500,000
| +109% | +$17.8K |
|
118
Sea Limited
SE
$113B
| $34.2K | 0.15% |
285,237
+106,465
| +60% | +$12.8K |
|
119
US Foods
USFD
$17.5B
| $33.2K | 0.15% |
883,410
-21,323
| -2% | -$802 |
|
120
Canadian Natural Resources
CNQ
$63.2B
| $33K | 0.15% |
969,942
-345,410
| -26% | -$11.7K |
|
121
Elevance Health
ELV
$70.6B
| $32.5K | 0.15% |
66,062
-14,698
| -18% | -$7.22K |
|
122
Axon Enterprise
AXON
$57.2B
| $32.3K | 0.15% |
234,656
+38,314
| +20% | +$5.28K |
|
123
Addus HomeCare
ADUS
$2.08B
| $32.3K | 0.15% |
346,297
-86,780
| -20% | -$8.1K |
|
124
ProAssurance
PRA
$1.22B
| $32.3K | 0.15% |
1,200,000
| – | – |
|
125
Bristol-Myers Squibb
BMY
$96B
| $31.9K | 0.14% |
437,401
-598,500
| -58% | -$43.7K |
|